Centre for Education and Research on Ageing, Concord Repatriation General Hospital , Sydney , Australia.
Biogerontology Group, ANZAC Research Institute, Concord Repatriation General Hospital , Sydney , Australia.
Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G144-G154. doi: 10.1152/ajpgi.00179.2018. Epub 2018 Oct 4.
Fenestrations are pores within liver sinusoidal endothelial cells (LSECs) that enable the transfer of substrates (particularly insulin and lipoproteins) between blood and hepatocytes. With increasing age, there are marked reductions in fenestrations, referred to as pseudocapillarization. Currently, fenestrations are thought to be regulated by vascular endothelial growth factor and nitric oxide (NO) pathways promoting remodeling of the actin cytoskeleton and cell membrane lipid rafts. We investigated the effects of drugs that act on these pathways on fenestrations in old (18-24 mo) and young mice (3-4 mo). Isolated LSECs were incubated with either cytochalasin 7-ketocholesterol, sildenafil, amlodipine, simvastatin, 2, 5-dimethoxy-4-iodoamphetamine (DOI), bosentan, TNF-related apoptosis-inducing ligand (TRAIL) or nicotinamide mononucleotide (NMN). LSECs were visualized under scanning electron microscopy to quantify fenestration porosity, diameter, and frequency, as well as direct stochastic optical reconstruction microscopy to examine actin and NO synthase. In young and old LSECs, fenestration porosity, diameter and frequency were increased by 7-ketocholesterol, while porosity and/or frequency were increased with NMN, sildenafil, amlodipine, TRAIL, and cytochalasin D. In old mice only, bosentan and DOI increased fenestration porosity and/or frequency. Modification of the actin cytoskeleton was observed with all agents that increased fenestrations, while NO synthase was only increased by sildenafil, amlodipine, and TRAIL. In conclusion, agents that target NO, actin, or lipid rafts promote changes in fenestrations in mice LSECs. Regulation of fenestrations occurs via both NO-dependent and independent pathways. This work indicates that age-related defenestration can be reversed pharmacologically, which has potential translational relevance for dyslipidemia and insulin resistance. NEW & NOTEWORTHY We demonstrate the effects of multiple nitric oxide-dependent and -independent pharmaceutical agents on fenestrations of the liver sinusoidal endothelium. Fenestrations are reorganized in response to nicotinamide mononucleotide, sildenafil, amlodipine, and TNF-related apoptosis-inducing ligand. This work indicates that age-related defenestration can be reversed pharmacologically, which has potential translational relevance for dyslipidemia and insulin resistance in old age.
窗孔是肝窦内皮细胞(LSEC)中的孔隙,可使血液和肝细胞之间的底物(尤其是胰岛素和脂蛋白)进行交换。随着年龄的增长,窗孔明显减少,称为假毛细血管化。目前,认为窗孔由血管内皮生长因子和一氧化氮(NO)途径调节,促进肌动蛋白细胞骨架和细胞膜脂筏的重塑。我们研究了作用于这些途径的药物对老年(18-24 个月)和年轻(3-4 个月)小鼠的窗孔的影响。用细胞松弛素 7-酮胆固醇、西地那非、氨氯地平、辛伐他汀、2,5-二甲氧基-4-碘苯乙胺(DOI)、波生坦、肿瘤坏死因子相关凋亡诱导配体(TRAIL)或烟酰胺单核苷酸(NMN)孵育分离的 LSEC。使用扫描电子显微镜观察 LSEC,以定量窗孔的孔隙率、直径和频率,以及直接随机光学重建显微镜检查肌动蛋白和一氧化氮合酶。在年轻和年老的 LSEC 中,7-酮胆固醇增加了窗孔的孔隙率、直径和频率,而 NMN、西地那非、氨氯地平、TRAIL 和细胞松弛素 D 增加了孔隙率和/或频率。仅在老年小鼠中,波生坦和 DOI 增加了窗孔的孔隙率和/或频率。所有增加窗孔的药物都观察到肌动蛋白细胞骨架的修饰,而只有西地那非、氨氯地平和 TRAIL 增加了一氧化氮合酶。总之,靶向 NO、肌动蛋白或脂筏的药物可促进小鼠 LSEC 中窗孔的变化。窗孔的调节通过依赖和不依赖于 NO 的途径发生。这项工作表明,与年龄相关的去窗孔化可以通过药理学逆转,这对于血脂异常和老年胰岛素抵抗具有潜在的转化意义。